Thursday, 13 August 2020


Allium wins $16.36 mn stent distribution deal in China

07 August 2013 | News | By BioSpectrum Bureau

Beijing King Health Investment will distribute Allium Medical's urinary tract stents for eight years in China

Beijing King Health Investment will distribute Allium Medical's urinary tract stents for eight years in China

Singapore: Israel-based Allium Medical signed a strategic agreement with Beijing King Health Investment to exclusively distribute its urinary tract stents for eight years in China.

King Health will buy the stents during the contract period and sales will begin in 2016, subject to obtaining permits from the China Food and Drug Administration (CFDA).

Mr Asaf Alperovitz, CEO, Allium, said that, "The agreement with Beijing King Health is strategic and vital for the company, both in terms of potential revenue and profits, and because of the foothold in Far Eastern markets."


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls